牛牛AI助理已提取核心訊息
Bristol-Myers Squibb Company (BMY) has issued a warning to its stockholders regarding an unsolicited mini-tender offer by Tutanota LLC to purchase up to 500,000 shares of BMY's common stock at $55.00 per share. This offer represents less than 0.025% of the company's outstanding common stock as of February 6, 2024. On February 14, 2024, BMY released a press statement advising shareholders to reject the offer, which is below the current market price and subject to numerous conditions, including Tutanota obtaining financing. The company emphasized that the offer is not endorsed by BMY and recommended that stockholders who have already tendered shares withdraw them before the offer's expiration at 5:00 p.m. ET on February 23, 2024. BMY also highlighted the risks associated with mini-tender offers, which are for less than 5% of a company's shares and are not subject to the same SEC disclosure and procedural requirements as larger tender offers.
Bristol-Myers Squibb Company (BMY) has issued a warning to its stockholders regarding an unsolicited mini-tender offer by Tutanota LLC to purchase up to 500,000 shares of BMY's common stock at $55.00 per share. This offer represents less than 0.025% of the company's outstanding common stock as of February 6, 2024. On February 14, 2024, BMY released a press statement advising shareholders to reject the offer, which is below the current market price and subject to numerous conditions, including Tutanota obtaining financing. The company emphasized that the offer is not endorsed by BMY and recommended that stockholders who have already tendered shares withdraw them before the offer's expiration at 5:00 p.m. ET on February 23, 2024. BMY also highlighted the risks associated with mini-tender offers, which are for less than 5% of a company's shares and are not subject to the same SEC disclosure and procedural requirements as larger tender offers.
百時美施貴寶公司（BMY）已就Tutanota LLC主動提出的小型招標要約向其股東發出警告，該要約以每股55.00美元的價格購買BMY的多達50萬股普通股。截至2024年2月6日，該報價佔該公司已發行普通股的不到0.025％。2024年2月14日，BMY發佈了一份新聞聲明，建議股東拒絕該要約，該要約低於當前的市場價格，並受許多條件的約束，包括Tutanota獲得融資。該公司強調該要約未得到BMY的認可，並建議已經投標股票的股東在要約於美國東部時間2024年2月23日下午 5:00 到期之前撤回股票。BMY還強調了與小型招標要約相關的風險，這些要約涉及不到公司5％的股份，並且不受與更大規模的要約相同的美國證券交易委員會披露和程序要求的約束。
百時美施貴寶公司（BMY）已就Tutanota LLC主動提出的小型招標要約向其股東發出警告，該要約以每股55.00美元的價格購買BMY的多達50萬股普通股。截至2024年2月6日，該報價佔該公司已發行普通股的不到0.025％。2024年2月14日，BMY發佈了一份新聞聲明，建議股東拒絕該要約，該要約低於當前的市場價格，並受許多條件的約束，包括Tutanota獲得融資。該公司強調該要約未得到BMY的認可，並建議已經投標股票的股東在要約於美國東部時間2024年2月23日下午 5:00 到期之前撤回股票。BMY還強調了與小型招標要約相關的風險，這些要約涉及不到公司5％的股份，並且不受與更大規模的要約相同的美國證券交易委員會披露和程序要求的約束。
有用
沒用